What is Docdoc?
Docdoc operates as a premier patient empowerment entity, functioning as a sophisticated medical advisor for individuals navigating the complexities of modern healthcare. By maintaining a robust network of over 23,000 contracted medical professionals, the company provides a data-driven interface that synthesizes outcomes, pricing, and patient experiences. This proprietary intelligence allows users to secure high-quality care tailored to specific medical requirements, effectively transforming the traditional patient-provider dynamic. Through its focus on transparency and accessibility, Docdoc has established itself as a critical intermediary in the healthcare ecosystem, aiming to optimize clinical results while reducing the friction often associated with medical service selection.
How much funding has Docdoc raised?
Docdoc has raised a total of $8.6M across 1 funding round:
Series A
$8.6M
Series A (2015): $8.6M with participation from SparkLabs Global Ventures and Hong Leong Financial Group
Key Investors in Docdoc
SparkLabs Global Ventures
A seed-stage venture capital firm that focuses on identifying and supporting exceptional entrepreneurs building category-defining companies globally, providing practical guidance and mentorship for international scaling.
Hong Leong Financial Group
A multinational conglomerate headquartered in Singapore with a primary focus on financial services, managing a diverse portfolio across Asia Pacific and North America to drive long-term sustainable value.
What's next for Docdoc?
Following this major strategic investment, Docdoc is expected to prioritize the expansion of its data analytics capabilities and the deepening of its provider network. The company's roadmap likely involves scaling its digital health solutions to address the growing demand for personalized medical navigation in emerging markets. By utilizing the recent capital, Docdoc aims to further integrate its outcomes-based insights into broader healthcare systems, potentially fostering partnerships with insurers and large-scale health providers. As the firm transitions from its current growth phase toward broader market penetration, the focus will remain on maintaining the integrity of its proprietary data while scaling its operational footprint to meet the evolving needs of patients across the region.
See full Docdoc company page
